ESC TV at #ACC22 - Expert Insights on VALOR-HCM and MAVA-LTE Study

Our experts - Carlos Aguiar, Elena Arbelo, Davide Capodanno, Victoria Delgado, Isabel Goncalves, Stefan James, Carol Ann Remme and Giuseppe Rosano – bring you the highlights from trials released during ACC.22 and their impact on clinical practice.

Carlos Aguiar gives his insights on the VALOR-HCM (Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive hypertrophic cardiomyopathy) trial and the updated cumulative results of treatment with mavacamten from the EXPLORER-LTE cohort of the MAVA-LTE study in patients with obstructive hypertrophic cardiomyopathy

https://www.escardio.org/Congresses-&-Events/ESC-TV/ESC-Expert-Insights-at-ACC22

The video content has been made available for informational and educational purposes only and is aimed at a professional audience. It only represents the views and opinions of the original creators of such content.
The information contained in the video has not been approved by the French National Agency for the Safety of Medicines and Health Products (ANSM). Always seek the advice of your physician or another qualified health care provider with any questions you may have regarding a medical condition.

https://www.escardio.org

Видео ESC TV at #ACC22 - Expert Insights on VALOR-HCM and MAVA-LTE Study канала European Society of Cardiology